| Literature DB >> 19061509 |
T Verplancke1, S Van Looy, D Benoit, S Vansteelandt, P Depuydt, F De Turck, J Decruyenaere.
Abstract
BACKGROUND: Several models for mortality prediction have been constructed for critically ill patients with haematological malignancies in recent years. These models have proven to be equally or more accurate in predicting hospital mortality in patients with haematological malignancies than ICU severity of illness scores such as the APACHE II or SAPS II 1. The objective of this study is to compare the accuracy of predicting hospital mortality in patients with haematological malignancies admitted to the ICU between models based on multiple logistic regression (MLR) and support vector machine (SVM) based models.Entities:
Mesh:
Year: 2008 PMID: 19061509 PMCID: PMC2612652 DOI: 10.1186/1472-6947-8-56
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Figure 1Classification by a support vector machine algorithm is performed by transforming the input variables data set by means of a mathematical function into a higher dimensional input space in which separation is much easier. The basis of this new heuristic is that classification of a seemingly chaotic input space is possible by increasing the dimensionality of that input space and thereby finding a separating boundary i.e. hyperplane. e.g.: (a) A two-dimensional training with positive examples as black circles and negative examples as white circles. The true decision boundary, (x1)2 +(x2)2 ≤ 1, is also shown. (b) The same data after mapping into a three-dimensional input space ((x1)2, (x2)2, √2(x1)(x2)). The circular decision boundary in (a) becomes a linear decision boundary in three dimensions (b). (copyright permission from Prentice Hall).
Initial 12 input variables for model 1 before start of MLR and SVM modeling process and their descriptive statistics for the training and validation data sets.
| gender, % male | 58 | 65 |
| age, yrs | 55 (± 18) | 58 (± 15) |
| % high-grade malignancy | 61 | 54 |
| % active disease of relapse | 34 | 39 |
| % allogeneic bone marrow transplant./stem cell transplant. | 13 | 10 |
| weeks since BMT, median (IQR)* | 15 (54) | 8 (102) |
| % chemotherapy<3 we since ICU admission | 41 | 52 |
| days of hospitalisation before ICU admission, median (IQR) | 4(16) | 6(16) |
| % bacterial infection | 44 | 43 |
| APACHE II score | 24.5 (± 7.4) | 25 (± 7.4) |
| % ventilated on day 1 | 49 | 46 |
| % vasopressor need on day 1 | 41 | 49 |
training n = 252, validation n = 100; mean (± SD), except when indicated otherwise, *within subgroup with bone marrow transplantation.
Initial 17 input variables for model 2 before start of MLR and SVM modeling process and their descriptive statistics for the training and validation data sets.
| age, yrs | 55 (± 18) | 58 (± 15) |
| % high-grade malignancy | 61 | 54 |
| % active disease of relapse | 34 | 39 |
| % allogeneic bone marrow transplant./stem cell transplant. | 13 | 10 |
| days of hospitalisation before ICU admission, median (IQR) | 4 (16) | 6 (16) |
| % bacterial infection | 44 | 43 |
| pulse (/min) | 123 (± 28) | 118 (± 33) |
| mean blood pressure (MAP), mmHg | 73 (± 27) | 69 (± 22) |
| respiration frequency (/min) | 32 (± 10) | 33 (± 13) |
| Pa02/Fi02 (p/f) | 198 (± 130) | 194 (± 126) |
| platelets (1000/mm3) | 125 (± 700) | 90 (± 114) |
| urea<24 h (g/l) | 0.86 (± 59) | 0.82 (± 55) |
| creatinine<24 h (mg/dl) | 1.6 (± 1.08) | 1.7 (± 1.7) |
| albumin<24 h (g/dl) | 2.6 (± 1.97) | 2.4 (± 0.70) |
| prothrombin time (%)<24 h | 56 (± 20.7) | 57 (± 19.4) |
| % ventilated on day 1 | 49 | 46 |
| % vasopressor need on day 1 | 41 | 49 |
training n = 252, validation n = 100; mean (± SD), except when indicated otherwise.
MLR model 1: variables retained for final MLR analysis after variable selection process, coefficients, standard errors of the coefficients, odds ratios, 95% confidence intervals (CI) for the odds ratios for the model variables (x), and p-value.
| gender* | -.636 | .305 | .530 | .292–.962 | 0.037 |
| high-grade malignancy | .689 | .304 | 1.992 | 1.099–3.613 | 0.023 |
| active disease | .797 | .321 | 2.218 | 1.181–4.165 | 0.013 |
| bone marrow transplant. | .914 | .443 | 2.495 | 1.048–5.941 | 0.039 |
| bacterial infection | -.739 | .316 | .478 | .257–.887 | 0.019 |
| APACHE II (per point) | .084 | .024 | 1.088 | 1.037–1.140 | 0.001 |
| ventilation < 24 h | 1.221 | .323 | 3.391 | 1.800–6.388 | <0.001 |
| Constant | -2.006 | .707 | .135 | 0.005 |
*female gender
MLR model 2: variables retained for final MLR analysis after variable selection, coefficients, standard errors of the coefficients, odds ratios, 95% confidence intervals for the odds ratios for the model variables (x), and p-value
| High-grade malignancy | .670 | .324 | 1.954 | 1.034–3.690 | 0.039 |
| active disease | .850 | .328 | 2.340 | 1.229–4.456 | 0.010 |
| bacterial infection | -781 | .324 | .458 | .243–.863 | 0.016 |
| thrombocytopenia (<50.000/mm3) | .867 | .314 | 2.379 | 1.287–4.399 | 0.006 |
| ventilation < 24 h | 1.414 | .327 | 4.111 | 2.167–7.798 | <0.001 |
| prothrombin time (%) | -0.016 | .008 | .984 | .970–1.000 | 0.045 |
| PaO2/FiO2 (p/f) | -.003 | .001 | .997 | .995–1.000 | 0.025 |
| urea < 0.5 g/l (reference) | 0.011 | ||||
| urea 0.5–1 g/l | 0.583 | .415 | 1.791 | .876–.3.663 | 0.033 |
| urea > 1 g/l | 1.249 | .387 | 3.486 | 1.545–7.866 | 0.085 |
| Constant | -0.457 | .716 | 0.633 | 0.021 |
Accuracy (ACC), sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV) for model 1 and 2 for prediction of hospital mortality (95%CI)
| ACC | 0.730 | 0.680 | 0.740 | 0.680 |
| SN | 0.740 | 0.630 | 0.722 | 0.630 |
| SP | 0.717 | 0.740 | 0.761 | 0.739 |
| PPV | 0.755 | 0.740 | 0.780 | 0.739 |
| NPV | 0.702 | 0.630 | 0.700 | 0.630 |
Figure 2Area under the ROC curve (AUC) for comparison of the MLR and SVM in model 1.
Figure 3Area under the ROC curve (AUC) for comparison of the MLR and SVM in model 2.